Dog Welfare: Chronic Anxiety Disorder Management

Chronic anxiety disorders in dogs cause significant, persistent suffering. Understanding the range of evidence-based interventions improves outcomes for affected dogs.

Key Facts

Generalised anxiety disorder affects an estimated 14-20% of dogs in some studies
Chronic anxiety manifests as hypervigilance, reduced play, hiding, inappropriate elimination, and aggression
Anxiolytic medications including fluoxetine and clomipramine are effective first-line treatments
Medication is most effective when combined with behaviour modification and environmental management
Owner responses to anxious behaviour can inadvertently reinforce anxiety if not evidence-guided
Alpha-casozepine (Zylkene) and dog-appeasing pheromones offer mild anxiolytic effects for some dogs

Welfare Considerations

Chronic anxiety disorder represents a significant, persistent welfare burden for affected dogs and their owners. Dogs living with untreated or undertreated anxiety experience chronic negative emotional states that compromise their overall welfare quality of life. Many owners are unaware that effective treatment exists or mistake anxiety symptoms for personality traits. Welfare-positive management requires early recognition of anxiety, professional assessment by a clinical animal behaviourist, appropriate use of anxiolytic medication, and behaviour modification. Untreated chronic anxiety also increases risk of anxiety-related aggression, which threatens the human-animal bond.

What You Can Do

Seek professional assessment from a clinical animal behaviourist if your dog shows anxiety signs
Discuss long-term anxiolytic medication with your vet - medication is not a last resort
Learn behaviour modification techniques from a qualified professional rather than generic online sources
Support research into canine anxiety diagnosis and evidence-based treatment